Mortara Instrument
| Company type | Private |
|---|---|
| Industry | Medical technology |
| Founded | 1982 in Milwaukee, Wisconsin, United States |
| Founder | David W. Mortara |
| Fate | Acquired by Hill-Rom Holdings, Inc. in 2017 |
| Headquarters | Milwaukee , United States |
Area served | Worldwide |
Key people | David W. Mortara (founder) |
| Products | Diagnostic cardiology and patient monitoring products, ECG devices |
Number of employees | Over 400 |
| Parent | Hill-Rom Holdings, Inc. (since 2017) |
Mortara Instrument, Inc. was a U.S.-based private medical technology firm focusing on diagnostic cardiology and patient monitoring products. Established in 1982 by David W. Mortara in Milwaukee, Wisconsin, the company emerged as a prominent manufacturer of ECG devices. In 2017, Mortara was acquired by Hill-Rom Holdings, Inc. for $330 million and subsequently became part of the Welch Allyn brand portfolio.
History
The company was launched by physicist and former Marquette Electronics vice president David W. Mortara. Initially, Mortara Instrument developed medical devices for Marquette and other clients before shifting its focus to proprietary ECG equipment, competing with industry leaders such as GE Healthcare and Philips.
By 2016, Mortara had expanded its revenue approximately fivefold since 2000, reaching around $115 million. The firm employed over 400 personnel worldwide and maintained two substantial facilities in Milwaukee totaling more than 127,000 square feet.
In 2004, Mortara collaborated with the U.S. Food and Drug Administration to create a Digital ECG Warehouse aimed at supporting clinical research and therapeutic evaluations.
The acquisition in 2013 of the Quinton and Burdick product lines from Opko’s Cardiac Science broadened Mortara’s diagnostic cardiology offerings, placing a strong emphasis on advanced diagnostic algorithms and seamless integration with electronic medical records (EMR).
Hill-Rom completed its $330 million purchase of Mortara in February 2017, incorporating the company into its Front Line Care segment alongside Welch Allyn. This acquisition strengthened Hill-Rom’s global presence in diagnostic cardiology technologies.